Cargando…
History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs
Background: Despite major advances in its prevention and treatment, febrile neutropenia remains a most concerning complication of cancer chemotherapy. Outside the oncology setting, however, only few data are currently available on febrile neutropenia related to non-chemotherapy drugs. We report here...
Autores principales: | Andrès, Emmanuel, Mourot-Cottet, Rachel, Maloisel, Frédéric, Keller, Olivier, Vogel, Thomas, Séverac, François, Tebacher, Martine, Gottenberg, Jacques-Eric, Weber, Jean-Christophe, Kaltenbach, Georges, Goichot, Bernard, Sibilia, Jean, Korganow, Anne-Sophie, Herbrecht, Raoul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664007/ https://www.ncbi.nlm.nih.gov/pubmed/28954408 http://dx.doi.org/10.3390/jcm6100092 |
Ejemplares similares
-
Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases
por: Mourot-Cottet, Rachel, et al.
Publicado: (2016) -
Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center
por: Andrès, Emmanuel, et al.
Publicado: (2020) -
State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies
por: Andrès, Emmanuel, et al.
Publicado: (2019) -
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018) -
Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)